NCT06453473 Transfer Effects of Stationary Bicycle Perturbation Training on Older Adults' Cycling Skills
| NCT ID | NCT06453473 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Erlangen-Nürnberg Medical School |
| Condition | Older Adults |
| Study Type | INTERVENTIONAL |
| Enrollment | 127 participants |
| Start Date | 2025-03-12 |
| Primary Completion | 2027-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 127 participants in total. It began in 2025-03-12 with a primary completion date of 2027-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Israeli research group of this trial has developed the Perturbation Stationary Bicycle Robotics (PerStBiRo) system that can challenge balance while sitting. With this system, unexpected perturbations can be provided under controlled and safe conditions. Within the BiPerAge-project it will be evaluated if 20 training sessions (20 minutes each) on the PerStBiRo system will lead to transfer effects on safe cycling skills of community-dwelling older adults (age 65 years and older). The ability to cycle safely will be tested prior and after the training period using a cycling course, which consists of variant tasks requiring motor and cognitive skills.
Eligibility Criteria
Inclusion Criteria: * Ability and willingness to provide informed consent and accept randomization to either study arm * Ability to come to cycle course testing locations * ≥3 errors in pre-test of cycle course Exclusion Criteria: * Severe diseases e.g. ischemic heart disease which restricts exercise, chronic obstructive pulmonary disease (COPD), uncontrolled blood pressure, manifest osteoporosis or any other disease leading to increased fracture risks * A period less than one year after hip or knee replacement surgery or after fractures of the lower extremities * Amputation of a lower limb * Neurological diseases or 6-month after a stroke * Inability to ambulate independently * Severe visual impairments (blindness), non-compensable hearing * Cognitive impairment, scoring less than 24 on the MMSE (Mini-Mental State Examination), inability to understand and follow instructions * Participation in another intervention trial at the same time or within the previous 6 months
Contact & Investigator
Robert Kob, PhD
PRINCIPAL INVESTIGATOR
Institute for Biomedicine of Aging, Friederich-Alexander-Universität Erlangen-Nürnberg
Frequently Asked Questions
Who can join the NCT06453473 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, up to 100 Years, studying Older Adults. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06453473 currently recruiting?
Yes, NCT06453473 is actively recruiting participants. Contact the research team at robert.kob@fau.de for enrollment information.
Where is the NCT06453473 trial being conducted?
This trial is being conducted at Nuremberg, Germany, Beersheba, Israel.
Who is sponsoring the NCT06453473 clinical trial?
NCT06453473 is sponsored by University of Erlangen-Nürnberg Medical School. The principal investigator is Robert Kob, PhD at Institute for Biomedicine of Aging, Friederich-Alexander-Universität Erlangen-Nürnberg. The trial plans to enroll 127 participants.